Browse
Submit Data
Databases
API
Help
Login

Dataset Information

0 Views

3 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Alterations of mRNAs in MDBK cells expressing BPV-13 E5

ABSTRACT: To find out differentially expressed mRNAs in MDBK cells expressing BPV-13 E5 Overall design: A MDBK sample expressiong BPV-13 E5 and a negative control

INSTRUMENT(S): Illumina HiSeq 4000 (Bos taurus)

ORGANISM(S): Bos taurus

SUBMITTER: Feng Pang

PROVIDER: GSE133613 | GEO | 2019-07-02

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

primary

			Action	DRS
	GSE133613_MBDK-GFP-E5_vs_MBDK-GFP_Gene_differential_expression.txt.gz	Txt

Items per page:

1 - 1 of 1

Similar Datasets

Alterations of miRNAs in MDBK cells expressing BPV-13 E5

Project description:To find out differentially expressed miRNAs in MDBK cells expressing BPV-13 E5 Overall design: A MDBK sample expressiong BPV-13 E5 and a negative control

2019-07-02 | GSE133610 | GEO

Comprehensive analysis of differentially expressed microRNAs and mRNAs in MDBK cells expressing bovine papillomavirus E5 oncogene.

Project description:Delta bovine papillomaviruses (?BPVs) causes fibropapillomas or bladder cancer in cattle. E5 is the major oncogene of ?BPVs; however, the influence that E5 oncogene has on host microRNA (miRNA) and mRNA expression profiles remains little elucidated. In the present study, small RNA sequencing and RNA sequencing were used to explore alterations in miRNAs and mRNAs in E5 over-expressing Madin-Darby bovine kidney (MDBK) cells compared with controls. In total, 77 miRNAs (including 30 bovine-derived miRNAs) and 223 genes were differentially expressed (DE) following E5 overexpression. The dysregulated genes were mainly involved in metabolic and biosynthetic processes. We constructed a potential miRNA-gene regulatory network from the differentially expressed genes (DEGs) and DE miRNAs. Finally, 22 DEGs and nine DE miRNAs were selected for RT-qPCR validation. Of these, downregulation of six miRNAs, bta-miR-34c, bta-miR-122, bta-miR-195, bta-miR-449b, bta-miR-2425-5p, and bta-miR-2428-3p were confirmed; In addition, upregulation of 16 genes, ACSS2, DDIT4, INHBE, INSIG1, PNRC1, PSAT1, PSPH, PYCR1, SC4MOL, SLC34A2, SCD, SPARC, IDI1, PCK2, HMGCS1, and SMIM14 and downregulation of two genes, BATF3 and WFDC2 were confirmed. Specially, bta-miR-34c and bta-miR-449b potentially regulated PYCR1 and DDIT4, which were involved in cancer progression and angiogenesis. Our study presented for the first time the comprehensive miRNA and mRNA alterations in MDBK cells expressing the BPV E5 oncogene, providing new insights into the tumorigenesis induced by BPV E5.

2019-01-01 | S-EPMC6876490 | BioStudies

Alterations of mRNAs in MDBK cells expressing BPV-13 E5

Project description:Alterations of mRNAs in MDBK cells expressing BPV-13 E5

| PRJNA552044 | ENA

Alterations of miRNAs in MDBK cells expressing BPV-13 E5

Project description:Alterations of miRNAs in MDBK cells expressing BPV-13 E5

| PRJNA552043 | ENA

Alterations of miRNAs and mRNAs in MDBK cells expressing BPV-13 E5

Project description:Alterations of miRNAs and mRNAs in MDBK cells expressing BPV-13 E5

| PRJNA552035 | ENA

Alterations of miRNAs and mRNAs in MDBK cells expressing BPV-13 E5

Project description:This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series

2019-07-02 | GSE133614 | GEO

Alterations of mRNAs in NIH/3T3 cells overexpressing BPV-13 E6

Project description:To find out differentially expressed mRNAs in NIH/3T3 cells overexpressing BPV-13 E6 Overall design: Three NIH/3T3 samples expressing BPV-13 E6 and three negative controls

2019-04-11 | GSE129593 | GEO

Bovine papillomavirus type 2 (BPV-2) E5 oncoprotein binds to the subunit D of the V?-ATPase proton pump in naturally occurring urothelial tumors of the urinary bladder of cattle.

Project description:<h4>Background</h4>Active infection by bovine papillomavirus type 2 (BPV-2) was documented for fifteen urinary bladder tumors in cattle. Two were diagnosed as papillary urothelial neoplasm of low malignant potential (PUNLMP), nine as papillary and four as invasive urothelial cancers.<h4>Methods and findings</h4>In all cancer samples, PCR analysis revealed a BPV-2-specific 503 bp DNA fragment. E5 protein, the major oncoprotein of the virus, was shown both by immunoprecipitation and immunohistochemical analysis. E5 was found to bind to the activated (phosphorylated) form of the platelet derived growth factor ? receptor. PDGF?R immunoprecipitation from bladder tumor samples and from normal bladder tissue used as control revealed a protein band which was present in the pull-down from bladder cancer samples only. The protein was identified with mass spectrometry as "V?-ATPase subunit D", a component of the central stalk of the V?-ATPase vacuolar pump. The subunit D was confirmed in this complex by coimmunoprecipitation investigations and it was found to colocalize with the receptor. The subunit D was also shown to be overexpressed by Western blot, RT-PCR and immunofluorescence analyses. Immunoprecipitation and immunofluorescence also revealed that E5 oncoprotein was bound to the subunit D.<h4>Conclusion</h4>For the first time, a tri-component complex composed of E5/PDGF?R/subunit D has been documented in vivo. Previous in vitro studies have shown that the BPV-2 E5 oncoprotein binds to the proteolipid c ring of the V?-ATPase sector. We suggest that the E5/PDGF?R/subunit D complex may perturb proteostasis, organelle and cytosol homeostasis, which can result in altered protein degradation and in autophagic responses.

2014-01-01 | S-EPMC3933332 | BioStudies

Alterations of miRNAs in NIH/3T3 cells overexpressing BPV-13 E6

Project description:To find out differentially expressed miRNAs in NIH/3T3 cells overexpressing BPV-13 E6 Overall design: Three NIH/3T3 samples expressing BPV-13 E6 and three negative controls

2019-04-11 | GSE129592 | GEO

Artificial transmembrane oncoproteins smaller than the bovine papillomavirus E5 protein redefine sequence requirements for activation of the platelet-derived growth factor beta receptor.

Project description:The bovine papillomavirus E5 protein (BPV E5) is a 44-amino-acid homodimeric transmembrane protein that binds directly to the transmembrane domain of the platelet-derived growth factor (PDGF) beta receptor and induces ligand-independent receptor activation. Three specific features of BPV E5 are considered important for its ability to activate the PDGF beta receptor and transform mouse fibroblasts: a pair of C-terminal cysteines, a transmembrane glutamine, and a juxtamembrane aspartic acid. By using a new genetic technique to screen libraries expressing artificial transmembrane proteins for activators of the PDGF beta receptor, we isolated much smaller proteins, from 32 to 36 residues, that lack all three of these features yet still dimerize noncovalently, specifically activate the PDGF beta receptor via its transmembrane domain, and transform cells efficiently. The primary amino acid sequence of BPV E5 is virtually unrecognizable in some of these proteins, which share as few as seven consecutive amino acids with the viral protein. Thus, small artificial proteins that bear little resemblance to a viral oncoprotein can nevertheless productively interact with the same cellular target. We speculate that similar cellular proteins may exist but have been overlooked due to their small size and hydrophobicity.

2009-01-01 | S-EPMC2748040 | BioStudies

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data